Upregulating Aggregation-Induced-Emission Nanoparticles with Blood-Tumor-Barrier Permeability for Precise Photothermal Eradication of Brain Tumors and Induction of Local Immune Responses

© 2021 Wiley-VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 33(2021), 22 vom: 23. Juni, Seite e2008802
1. Verfasser: Zhang, Ming (VerfasserIn)
Weitere Verfasser: Wang, Wentao, Mohammadniaei, Mohsen, Zheng, Tao, Zhang, Qicheng, Ashley, Jon, Liu, Shunjie, Sun, Yi, Tang, Ben Zhong
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2021
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article glioblastoma immune response magnetic resonance photothermal therapy Bradykinin S8TIM42R2W
LEADER 01000caa a22002652c 4500
001 NLM324472390
003 DE-627
005 20250301122853.0
007 cr uuu---uuuuu
008 231225s2021 xx |||||o 00| ||eng c
024 7 |a 10.1002/adma.202008802  |2 doi 
028 5 2 |a pubmed25n1081.xml 
035 |a (DE-627)NLM324472390 
035 |a (NLM)33893670 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Zhang, Ming  |e verfasserin  |4 aut 
245 1 0 |a Upregulating Aggregation-Induced-Emission Nanoparticles with Blood-Tumor-Barrier Permeability for Precise Photothermal Eradication of Brain Tumors and Induction of Local Immune Responses 
264 1 |c 2021 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 24.07.2024 
500 |a Date Revised 24.07.2024 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a © 2021 Wiley-VCH GmbH. 
520 |a Compared to other tumors, glioblastoma (GBM) is extremely difficult to treat. Recently, photothermal therapy (PTT) has demonstrated advanced therapeutic efficacy; however, because of the relatively low tissue-penetration efficiency of laser light, its application in deep-seated tumors remains challenging. Herein, bradykinin (BK) aggregation-induced-emission nanoparticles (BKAIE NPs) are synthesized; these offer selective penetration through the blood-tumor barrier (BTB) and strong absorbance in the near-infrared region (NIR). The BK ligand can prompt BTB adenosine receptor activation, which enhances transportation and accumulation inside tumors, as confirmed by T1 -weighted magnetic resonance and fluorescence imaging. The BK@AIE NPs exhibit high photothermal conversion efficiency under 980 nm NIR laser irradiation, facilitating the treatment of deep-seated tumors. Tumor progression can be effectively inhibited to extend the survival span of mice after spatiotemporal PTT. NIR irradiation can eradicate tumor tissues and release tumor-associated antigens. It is observed that the PTT treatment of GBM-bearing mice activates natural killer cells, CD3+ T cells, CD8+ T cells, and M1 macrophages in the GBM area, increasing the therapeutic efficacy. This study demonstrates that NIR-assisted BK@AIE NPs represent a promising strategy for the improved systematic elimination of GBMs and the activation of local brain immune privilege 
650 4 |a Journal Article 
650 4 |a glioblastoma 
650 4 |a immune response 
650 4 |a magnetic resonance 
650 4 |a photothermal therapy 
650 7 |a Bradykinin  |2 NLM 
650 7 |a S8TIM42R2W  |2 NLM 
700 1 |a Wang, Wentao  |e verfasserin  |4 aut 
700 1 |a Mohammadniaei, Mohsen  |e verfasserin  |4 aut 
700 1 |a Zheng, Tao  |e verfasserin  |4 aut 
700 1 |a Zhang, Qicheng  |e verfasserin  |4 aut 
700 1 |a Ashley, Jon  |e verfasserin  |4 aut 
700 1 |a Liu, Shunjie  |e verfasserin  |4 aut 
700 1 |a Sun, Yi  |e verfasserin  |4 aut 
700 1 |a Tang, Ben Zhong  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Advanced materials (Deerfield Beach, Fla.)  |d 1998  |g 33(2021), 22 vom: 23. Juni, Seite e2008802  |w (DE-627)NLM098206397  |x 1521-4095  |7 nnas 
773 1 8 |g volume:33  |g year:2021  |g number:22  |g day:23  |g month:06  |g pages:e2008802 
856 4 0 |u http://dx.doi.org/10.1002/adma.202008802  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 33  |j 2021  |e 22  |b 23  |c 06  |h e2008802